New York Cancer & Blood Specialists’ Post

Join us on the 28th of May, from 17:00-18:00, for the webinar 'Breast cancer diagnostics today: Is a sensitive liquid biopsy the missing piece?'. This webinar, featuring leading expert Professor Nicola Fusco, explores the applications of liquid biopsy - a minimally invasive approach analysing tumor DNA circulating in blood. #BreastCancer #LiveWebinar #LiquidBiopsy #CaresphereAcademy #SysmexLifeScience #SysmexBNL

Join us on the 28th of May, from 17:00-18:00, for the webinar 'Breast cancer diagnostics today: Is a sensitive liquid biopsy the missing piece?'. This webinar, featuring leading expert Professor Nicola Fusco, explores the applications of liquid biopsy - a minimally invasive approach analysing tumor DNA circulating in blood. #BreastCancer #LiveWebinar #LiquidBiopsy #CaresphereAcademy #SysmexLifeScience #SysmexBNL

Day 5 By understanding the different types of prostate cancer, we can shed light on the unique aspects of each subtype and discuss their implications for diagnosis, treatment, and prognosis. Join us as we dive into the various types of prostate cancer and their distinct features. https://lnkd.in/dfJzAnFb

In this new retrospective study published in July, two #AI-powered mammography solutions were evaluated head-to-head, to compare results of breast cancer detection. #ProFoundAI performed significantly better than the other solution for breast cancer detection, particularly in patients with non-dense breasts (AUC, 0.93; P < .001). Explore the study: https://bit.ly/3WGGiLY #EarlyDetection, #BreastAI, #iCAD, #RadiologyAI

Join us for part 2 of our CME series focused on patient journeys in the advancing therapeutic landscape of advanced prostate cancer. This webcast will describe the burden and impact on quality of life associated with advanced prostate cancer. Watch now: https://okt.to/l4uAW3

Coming up at the 13th Annual WCS Winter Cancer Symposium: Explore cutting-edge developments in front-line therapy for solid tumors and hematologic malignancies, including Supportive Care, Biosimilars, Liquid Biopsies, and more. From managing adverse events of CPI to advances in breast cancer treatments, this symposium covers it all. Don't miss out - Register now! 🌟 #WCSWinterSymposium #CancerResearch #medicaladvancements

#ProstateCancer is the most common cancer in men in the UK. As part of our '25 at 25' anniversary series, we look back at the many achievements of the #STAMPEDEtrial. Since 2005, we have tested 10 different treatments, and changed the standard-of-care for advanced prostate cancer four times. Read more about this ground-breaking trial on our website. 👉 https://bit.ly/3TmrcdV #MensHealth #UrologicalCancerAwarenessMonth

This Fingerprint Test Could Soon Replace the Mammogram for Breast Cancer Screening https://ow.ly/or3Q50QnRng #fingerprintbreastscreening #screeningmammogram #screeningforbreastcancer #mammogram

Dr Karen Van Baelen unveils critical findings at SABCS 2023 from the UPTIDER program. Key insights reveal unseen metastases in lobular breast cancer, challenging current diagnostic approaches. Discoveries emphasise the vital role of detailed microscopic examinations and the persistence of ER status, urging a reevaluation of treatment strategies. Discover these vital insights. 👇 For all SABCS 2023 videos, find the link in the comments! #SABCS2023 #BreastCancerAwareness #UPTIDERStudy #OncologyInnovation

Discover how circulating tumor DNA (ctDNA) is revolutionizing cancer detection and monitoring. In this blog, we discuss ctDNA's benefits over traditional biopsies, current applications, and prospects in personalized cancer care. https://lnkd.in/eBHZsYXG #blog #colorectalcancer #breastcancer #lungcancer #nsclc #bladdercancer #patienteducation #PRIMR